Company intelligence / Profile preview

The Catherine

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Catherine is a biotechnology company focused on female reproductive longevity and women's health. The company aims to develop therapeutic interventions that delay ovarian aging and mitigate the health impacts of menopause, thereby extending the healthy lifespan of women. By targeting the biological mechanisms of reproductive decline, Catherine seeks to improve overall health outcomes and quality of life for women as they age. The company operates at the intersection of longevity science and women's health, utilizing advanced research to address unmet needs in female-specific aging processes.

Therapeutic areas: Women's Health
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on The Catherine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Catherine.

Explore the full profile